Preliminary Cancer Incidence Rates and Trends: Preliminary Estimates for 2017

The most recent preliminary estimates of incidence rates and trends are for 2000-2017. Users should refer to the official rates for 1975-2018 in SEER*Explorer, which was released in April 2021.

Based on results from the February 2019 SEER submission of cases for 2017 rates and trends, the following figures and tables are presented. Caution is advised when interpreting these figures and tables, as these are preliminary results and are subject to change for 2017 with the addition of data from more recent case submissions.

Data are also available for download for use in your own software.

Preliminary 5-year Trends
Preliminary 5-year Rates
Long-Term Trend Comparison

Preliminary 5-year Average Annual Percent Change (AAPC) Estimates
Based on Joinpoint Analyses 2000-2017

February 2019 SEER Submission, SEER 18 Registries

Select a Graph:

Preliminary 5-year AAPC Estimates
Male, All Races

Preliminary 5-year AAPC Estimates
Female, All Races

Preliminary 5-year AAPC Estimates
Male, White

Preliminary 5-year AAPC Estimates
Female, White

Preliminary 5-year AAPC Estimates
Male, Black

Preliminary 5-year AAPC Estimates
Female, Black

The graph above presents the Average Annual Percent Change (What is an AAPC?) for 2013-2017 based on the preliminary rates through 2017.
The Joinpoint analyses on the series allowed up to 3 Joinpoints in the trend.
The underlying rates in the analysis were adjusted for reporting delay in the registry.
* The AAPC is significantly different from zero (p<.05).

5-year Delay-Adjusted Rates^a

February 2019 SEER Submission (2000-2017), SEER 18 Registries

Choose a Cancer Site:

Cancer Site	Sex	Race	Delay-adjusted rates ^a 2013-2017
All Sites	Male	All Races	476.6
		White	484.6
		Black	528.7
	Female	All Races	416.0
		White	431.9
		Black	407.4
All Sites (Ages 0-19)	Male	All Races	19.3
		White	20.6
		Black	14.1
	Female	All Races	18.0
		White	19.1
		Black	13.8
Brain and Other Nervous System	Male	All Races	7.6
		White	8.3
		Black	4.7
	Female	All Races	5.4
		White	6.0
		Black	3.5
Breast	Female	All Races	127.3
		White	129.8
		Black	129.1
Cervix	Female	All Races	7.5
		White	7.5
		Black	8.3
Colon and Rectum	Male	All Races	44.1
		White	43.5
		Black	53.4
	Female	All Races	34.0
		White	33.7
		Black	40.7
Corpus and Uterus NOS	Female	All Races	26.8
		White	27.4
		Black	26.5
Esophagus	Male	All Races	7.1
		White	7.6
		Black	6.1
	Female	All Races	1.7
		White	1.7
		Black	2.1
Hodgkin Lymphoma	Male	All Races	2.8
		White	3.0
		Black	3.0
	Female	All Races	2.2
		White	2.4
		Black	2.2
Kidney and Renal Pelvis	Male	All Races	22.5
		White	23.1
		Black	25.9
	Female	All Races	11.3
		White	11.7
		Black	13.3
Larynx	Male	All Races	4.9
		White	4.9
		Black	7.9
	Female	All Races	1.0
		White	1.1
		Black	1.5
Leukemia	Male	All Races	18.9
		White	20.4
		Black	14.9
	Female	All Races	11.5
		White	12.3
		Black	9.7
Liver and Intrahepatic Bile Duct	Male	All Races	14.1
		White	12.8
		Black	17.9
	Female	All Races	5.0
		White	4.6
		Black	5.4
Lung and Bronchus	Male	All Races	61.0
		White	61.2
		Black	77.0
	Female	All Races	47.1
		White	49.7
		Black	47.0
Melanoma of the Skin	Male	All Races	30.8
		White	36.9
		Black	1.2
	Female	All Races	18.6
		White	22.9
		Black	0.9
Myeloma	Male	All Races	9.0
		White	8.5
		Black	17.6
	Female	All Races	5.8
		White	5.1
		Black	12.9
Non-Hodgkin Lymphoma	Male	All Races	23.8
		White	25.1
		Black	18.0
	Female	All Races	16.1
		White	17.0
		Black	12.5
Oral Cavity and Pharynx	Male	All Races	17.5
		White	18.5
		Black	14.1
	Female	All Races	6.4
		White	6.7
		Black	5.1
Ovary	Female	All Races	11.2
		White	11.7
		Black	9.3
Pancreas	Male	All Races	14.7
		White	14.8
		Black	17.6
	Female	All Races	11.5
		White	11.4
		Black	14.6
Prostate	Male	All Races	108.4
		White	102.7
		Black	177.0
Stomach	Male	All Races	9.6
		White	8.7
		Black	13.5
	Female	All Races	5.2
		White	4.6
		Black	7.2
Testis	Male	All Races	5.9
		White	7.1
		Black	1.6
Thyroid	Male	All Races	7.4
		White	8.0
		Black	3.9
	Female	All Races	21.5
		White	22.9
		Black	13.5
Urinary Bladder	Male	All Races	33.6
		White	37.0
		Black	20.5
	Female	All Races	8.2
		White	8.9
		Black	6.9
^aRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

Joinpoint Trend Analyses

November 2018 SEER Submission (2000-2016) and
February 2019 SEER Submission (2000-2017)
SEER 18 Registries

The numbers presented in the table below represent the Annual Percent Change (APC) in incidence rates. An APC is estimated based on a model that fits a linear trend to the log of the annual incidence rate. This model also estimates whether a trend changes significantly in direction or magnitude and, if it does, determines when the change(s) occurs. If a trend does not change over time, then there is only one estimate provided for the entire time period. If there is one or more points where a trend changes, the table shows each APC estimate and the years for which each estimate applies. The analyses allowed up to 3 changes (joinpoints) to occur in the trend.For more information about the model used to estimate these trends, visit Joinpoint Trend Analysis Software.

Choose a Cancer Site:

Cancer Site	Sex	Race	November 2018 Submission Joinpoint Trends		February 2019 Submission Preliminary Joinpoint Trends
Cancer Site	Sex	Race	Annual Percent Change, 2000-2016 APC (Year Range)	Average Annual Percent Change, 2012-2016	Annual Percent Change, 2000-2017 APC (Year Range)	Average Annual Percent Change, 2013-2017
All Sites	Male	All Races	-0.7* (2000-08) -2.0* (2008-16)	-2.0*	-0.8* (2000-08) -1.8* (2008-17)	-1.8*
		White	-0.6* (2000-08) -1.9* (2008-16)	-1.9*	-0.7* (2000-08) -1.8* (2008-17)	-1.8*
		Black	-1.8* (2000-06) -0.2 (2006-09) -3.7* (2009-14) -0.2 (2014-16)	-1.9*	-1.9* (2000-17)	-1.9*
	Female	All Races	-0.1 (2000-16)	-0.1	-0.8* (2000-05) 0.9 (2005-08) -0.1 (2008-17)	-0.1
		White	0.0 (2000-16)	0.0	-1.1 (2000-03) 0.1 (2003-17)	0.1
		Black	0.1 (2000-16)	0.1	0.1 (2000-17)	0.1
All Sites (Ages 0-19)	Male	All Races	0.7* (2000-16)	0.7*	0.7* (2000-17)	0.7*
		White	0.6* (2000-16)	0.6*	0.6* (2000-17)	0.6*
		Black	1.3* (2000-16)	1.3*	1.1* (2000-17)	1.1*
	Female	All Races	1.2* (2000-16)	1.2*	1.1* (2000-17)	1.1*
		White	1.1* (2000-16)	1.1*	1.1* (2000-17)	1.1*
		Black	1.4* (2000-16)	1.4*	1.4* (2000-17)	1.4*
Brain and Other Nervous System	Male	All Races	-0.3* (2000-16)	-0.3*	-0.2* (2000-17)	-0.2*
		White	-0.2 (2000-16)	-0.2	-0.2 (2000-17)	-0.2
		Black	-0.2 (2000-16)	-0.2	-0.1 (2000-17)	-0.1
	Female	All Races	-0.3 (2000-16)	-0.3	-0.3* (2000-17)	-0.3*
		White	-0.2 (2000-16)	-0.2	-0.1 (2000-17)	-0.1
		Black	-0.6 (2000-16)	-0.6	-0.5 (2000-17)	-0.5
Breast	Female	All Races	-2.3* (2000-04) 0.3* (2004-16)	0.3*	-2.4* (2000-04) 0.3* (2004-17)	0.3*
		White	-2.5* (2000-04) 0.2 (2004-16)	0.2	-2.6* (2000-04) 0.2 (2004-17)	0.2
		Black	0.6* (2000-16)	0.6*	0.6* (2000-17)	0.6*
Cervix	Female	All Races	-3.8* (2000-03) -1.5* (2003-13) 1.2 (2013-16)	0.5	-4.0* (2000-03) -1.4* (2003-13) 0.7 (2013-17)	0.7
		White	-4.8* (2000-03) -0.1 (2003-08) -2.2* (2008-13) 2.8* (2013-16)	1.5*	-4.7* (2000-03) -0.6* (2003-17)	-0.6*
		Black	-2.7* (2000-16)	-2.7*	-2.6* (2000-17)	-2.6*
Colon and Rectum	Male	All Races	-2.5* (2000-08) -4.1* (2008-11) -1.4* (2011-16)	-1.4*	-2.6* (2000-17)	-2.6*
		White	-3.0* (2000-12) -1.4 (2012-16)	-1.4	-3.0* (2000-12) -1.5* (2012-17)	-1.5*
		Black	-2.5* (2000-16)	-2.5*	-2.5* (2000-17)	-2.5*
	Female	All Races	-2.1* (2000-08) -3.0* (2008-13) -0.2 (2013-16)	-0.9	-2.2* (2000-17)	-2.2*
		White	-2.4* (2000-13) -0.2 (2013-16)	-0.8	-2.4* (2000-13) -0.5 (2013-17)	-0.5
		Black	-1.3* (2000-06) -2.9* (2006-16)	-2.9*	-2.4* (2000-17)	-2.4*
Corpus and Uterus NOS	Female	All Races	-1.5 (2000-03) 1.5* (2003-16)	1.5*	-1.7 (2000-03) 1.5* (2003-17)	1.5*
		White	-1.9 (2000-03) 1.3* (2003-16)	1.3*	-2.0 (2000-03) 1.3* (2003-17)	1.3*
		Black	2.4* (2000-16)	2.4*	2.3* (2000-17)	2.3*
Esophagus	Male	All Races	-1.0* (2000-16)	-1.0*	-0.9* (2000-17)	-0.9*
		White	-0.4* (2000-16)	-0.4*	-0.3* (2000-17)	-0.3*
		Black	-4.7* (2000-16)	-4.7*	-4.6* (2000-17)	-4.6*
	Female	All Races	-1.6* (2000-16)	-1.6*	-1.6* (2000-17)	-1.6*
		White	-1.0* (2000-16)	-1.0*	-1.0* (2000-17)	-1.0*
		Black	-3.9* (2000-16)	-3.9*	-3.8* (2000-17)	-3.8*
Hodgkin Lymphoma	Male	All Races	1.0 (2000-07) -1.5* (2007-16)	-1.5*	1.1 (2000-07) -1.7* (2007-17)	-1.7*
		White	1.1 (2000-07) -1.7* (2007-16)	-1.7*	1.1 (2000-07) -1.9* (2007-17)	-1.9*
		Black	0.3 (2000-16)	0.3	0.0 (2000-17)	0.0
	Female	All Races	2.3 (2000-05) -1.6* (2005-16)	-1.6*	2.9 (2000-04) -1.3* (2004-17)	-1.3*
		White	2.1 (2000-05) -1.7* (2005-16)	-1.7*	1.0 (2000-07) -1.8* (2007-17)	-1.8*
		Black	0.3 (2000-16)	0.3	0.2 (2000-17)	0.2
Kidney and Renal Pelvis	Male	All Races	3.0* (2000-08) 0.5* (2008-16)	0.5*	2.4* (2000-05) 4.3* (2005-08) -0.8 (2008-11) 1.1* (2011-17)	1.1*
		White	2.9* (2000-08) 0.6* (2008-16)	0.6*	2.9* (2000-08) 0.6* (2008-17)	0.6*
		Black	3.4* (2000-08) 0.4 (2008-16)	0.4	3.2* (2000-09) 0.0 (2009-17)	0.0
	Female	All Races	3.6* (2000-07) 0.5 (2007-16)	0.5	3.5* (2000-07) 0.7* (2007-17)	0.7*
		White	4.1* (2000-06) 0.7* (2006-16)	0.7*	4.0* (2000-06) 0.9* (2006-17)	0.9*
		Black	4.0* (2000-08) 0.8 (2008-16)	0.8	1.2 (2000-05) 7.9 (2005-08) 0.2 (2008-17)	0.2
Larynx	Male	All Races	-4.4* (2000-03) -1.7* (2003-10) -3.3* (2010-16)	-3.3*	-4.5* (2000-03) -1.8* (2003-11) -3.6* (2011-17)	-3.6*
		White	-2.3* (2000-16)	-2.3*	-4.2* (2000-03) -1.5* (2003-11) -3.7* (2011-17)	-3.7*
		Black	-3.3* (2000-16)	-3.3*	-3.2* (2000-17)	-3.2*
	Female	All Races	-2.1* (2000-16)	-2.1*	-2.2* (2000-17)	-2.2*
		White	-2.0* (2000-16)	-2.0*	-2.1* (2000-17)	-2.1*
		Black	-1.7* (2000-16)	-1.7*	-1.8* (2000-17)	-1.8*
Leukemia	Male	All Races	-0.5 (2000-07) 3.0 (2007-10) 0.4 (2010-16)	0.4	-0.7 (2000-06) 2.0* (2006-12) -0.1 (2012-17)	-0.1
		White	-0.1 (2000-06) 1.4* (2006-16)	1.4*	-0.4 (2000-06) 1.8* (2006-13) -0.2 (2013-17)	-0.2
		Black	0.5 (2000-16)	0.5	0.5 (2000-17)	0.5
	Female	All Races	0.8* (2000-16)	0.8*	0.9* (2000-17)	0.9*
		White	1.0* (2000-16)	1.0*	1.0* (2000-17)	1.0*
		Black	-1.2 (2000-07) 2.2* (2007-16)	2.2*	-1.6* (2000-07) 3.3* (2007-12) 0.4 (2012-17)	0.4
Liver and Intrahepatic Bile Duct	Male	All Races	4.2* (2000-09) 2.3* (2009-14) -1.4 (2014-16)	0.4	1.4 (2000-02) 4.8* (2002-08) 2.3* (2008-15) -2.1 (2015-17)	0.1
		White	-0.8 (2000-02) 7.6* (2002-05) 3.6* (2005-14) -2.2 (2014-16)	0.6	0.2 (2000-02) 5.6* (2002-08) 3.1* (2008-14) -0.3 (2014-17)	0.6
		Black	3.1* (2000-16)	3.1*	3.5* (2000-15) -5.2 (2015-17)	-0.9
	Female	All Races	2.9* (2000-16)	2.9*	3.0* (2000-17)	3.0*
		White	-0.3 (2000-03) 4.3* (2003-14) -0.8 (2014-16)	1.7	0.2 (2000-03) 3.9* (2003-17)	3.9*
		Black	3.2* (2000-16)	3.2*	2.9* (2000-17)	2.9*
Lung and Bronchus	Male	All Races	-1.9* (2000-08) -3.1* (2008-16)	-3.1*	-2.0* (2000-08) -2.9* (2008-17)	-2.9*
		White	-1.8* (2000-08) -3.1* (2008-16)	-3.1*	-1.9* (2000-08) -2.9* (2008-17)	-2.9*
		Black	-2.8* (2000-16)	-2.8*	-2.8* (2000-17)	-2.8*
	Female	All Races	0.1 (2000-07) -1.7* (2007-16)	-1.7*	0.0 (2000-07) -1.5* (2007-17)	-1.5*
		White	0.1 (2000-07) -1.7* (2007-16)	-1.7*	0.0 (2000-07) -1.5* (2007-17)	-1.5*
		Black	1.2* (2000-06) -1.8* (2006-16)	-1.8*	0.4 (2000-08) -1.9* (2008-17)	-1.9*
Melanoma of the Skin	Male	All Races	1.8* (2000-16)	1.8*	2.0* (2000-15) -2.4 (2015-17)	-0.2
		White	2.0* (2000-16)	2.0*	2.2* (2000-15) -2.8 (2015-17)	-0.3
		Black	-0.9 (2000-16)	-0.9	-0.5 (2000-17)	-0.5
	Female	All Races	1.4* (2000-16)	1.4*	1.4* (2000-17)	1.4*
		White	1.7* (2000-16)	1.7*	3.0* (2000-05) 0.6 (2005-12) 4.6 (2012-15) -3.0 (2015-17)	0.7
		Black	0.2 (2000-16)	0.2	-0.1 (2000-17)	-0.1
Myeloma	Male	All Races	1.7* (2000-16)	1.7*	0.4 (2000-06) 2.8* (2006-12) 0.7 (2012-17)	0.7
		White	1.6* (2000-16)	1.6*	1.6* (2000-17)	1.6*
		Black	1.6* (2000-16)	1.6*	1.6* (2000-17)	1.6*
	Female	All Races	-0.1 (2000-06) 2.1* (2006-16)	2.1*	-0.1 (2000-06) 2.0* (2006-17)	2.0*
		White	0.0 (2000-07) 2.1* (2007-16)	2.1*	-0.3 (2000-06) 2.0* (2006-17)	2.0*
		Black	2.0* (2000-16)	2.0*	2.0* (2000-17)	2.0*
Non-Hodgkin Lymphoma	Male	All Races	0.8* (2000-07) -0.3* (2007-16)	-0.3*	0.7* (2000-08) -0.4* (2008-17)	-0.4*
		White	0.9* (2000-07) -0.3* (2007-16)	-0.3*	0.9* (2000-07) -0.3* (2007-17)	-0.3*
		Black	0.1 (2000-16)	0.1	0.0 (2000-17)	0.0
	Female	All Races	1.0 (2000-04) -0.4* (2004-16)	-0.4*	-0.1 (2000-17)	-0.1
		White	0.6 (2000-06) -0.4* (2006-16)	-0.4*	-0.1 (2000-17)	-0.1
		Black	0.3 (2000-16)	0.3	0.4* (2000-17)	0.4*
Oral Cavity and Pharynx	Male	All Races	-0.5 (2000-05) 1.0* (2005-16)	1.0*	-0.5 (2000-05) 0.9* (2005-17)	0.9*
		White	1.1* (2000-16)	1.1*	-0.2 (2000-05) 1.5* (2005-15) -1.5 (2015-17)	0.0
		Black	-4.4* (2000-05) -1.3* (2005-16)	-1.3*	-4.9* (2000-05) -1.0* (2005-17)	-1.0*
	Female	All Races	0.1 (2000-16)	0.1	0.2 (2000-17)	0.2
		White	0.4* (2000-16)	0.4*	0.4* (2000-17)	0.4*
		Black	-0.9* (2000-16)	-0.9*	-1.0* (2000-17)	-1.0*
Ovary	Female	All Races	-1.5* (2000-16)	-1.5*	-1.6* (2000-17)	-1.6*
		White	-1.6* (2000-16)	-1.6*	-1.7* (2000-17)	-1.7*
		Black	-0.8* (2000-16)	-0.8*	-0.8* (2000-17)	-0.8*
Pancreas	Male	All Races	0.8* (2000-16)	0.8*	0.9* (2000-17)	0.9*
		White	1.0* (2000-16)	1.0*	1.0* (2000-17)	1.0*
		Black	0.2 (2000-16)	0.2	0.3 (2000-17)	0.3
	Female	All Races	0.8* (2000-16)	0.8*	0.9* (2000-17)	0.9*
		White	1.0* (2000-16)	1.0*	1.0* (2000-17)	1.0*
		Black	0.1 (2000-16)	0.1	0.2 (2000-17)	0.2
Prostate	Male	All Races	-1.8* (2000-10) -9.0* (2010-14) 3.9 (2014-16)	-2.7	-1.8* (2000-10) -8.8* (2010-14) 3.5 (2014-17)	0.3
		White	-1.9* (2000-10) -9.4* (2010-14) 4.0 (2014-16)	-2.9	-1.9* (2000-10) -9.2* (2010-14) 3.3 (2014-17)	0.0
		Black	-2.1* (2000-11) -9.6* (2011-14) 4.0 (2014-16)	-3.0	-2.1* (2000-11) -9.2 (2011-14) 2.9 (2014-17)	-0.2
Stomach	Male	All Races	-1.4* (2000-16)	-1.4*	-1.4* (2000-17)	-1.4*
		White	-1.1* (2000-16)	-1.1*	-1.1* (2000-17)	-1.1*
		Black	-0.8 (2000-08) -8.1 (2008-11) 2.6 (2011-14) -5.7 (2014-16)	-1.6	-2.3* (2000-17)	-2.3*
	Female	All Races	-0.5* (2000-16)	-0.5*	-0.5* (2000-17)	-0.5*
		White	-0.2 (2000-16)	-0.2	-0.2 (2000-17)	-0.2
		Black	-1.7* (2000-16)	-1.7*	-1.8* (2000-17)	-1.8*
Testis	Male	All Races	0.8* (2000-16)	0.8*	0.8* (2000-17)	0.8*
		White	0.8* (2000-16)	0.8*	0.8* (2000-17)	0.8*
		Black	1.2 (2000-16)	1.2	1.1 (2000-17)	1.1
Thyroid	Male	All Races	5.7* (2000-11) 1.0 (2011-16)	1.0	6.2* (2000-09) 2.7* (2009-15) -3.7 (2015-17)	-0.5
		White	6.1* (2000-10) 1.5* (2010-16)	1.5*	6.3* (2000-09) 2.6* (2009-15) -3.3 (2015-17)	-0.4
		Black	3.6* (2000-16)	3.6*	4.4* (2000-14) -5.7 (2014-17)	-3.3
	Female	All Races	6.9* (2000-09) 2.4* (2009-14) -1.8 (2014-16)	0.3	6.3* (2000-06) 8.0* (2006-09) 1.9* (2009-15) -5.4* (2015-17)	-1.8*
		White	7.1* (2000-09) 2.3* (2009-14) -1.6 (2014-16)	0.3	7.1* (2000-09) 2.1* (2009-15) -5.6* (2015-17)	-1.9*
		Black	5.7* (2000-14) -4.5 (2014-16)	0.5	5.8* (2000-14) -6.0* (2014-17)	-3.2
Urinary Bladder	Male	All Races	0.0 (2000-07) -1.5* (2007-16)	-1.5*	0.0 (2000-07) -1.4* (2007-17)	-1.4*
		White	0.0 (2000-07) -1.4* (2007-16)	-1.4*	0.0 (2000-07) -1.3* (2007-17)	-1.3*
		Black	-0.1 (2000-16)	-0.1	-0.2 (2000-17)	-0.2
	Female	All Races	-1.0* (2000-16)	-1.0*	-1.1* (2000-17)	-1.1*
		White	-0.9* (2000-16)	-0.9*	-1.0* (2000-17)	-1.0*
		Black	-0.7* (2000-16)	-0.7*	-0.8* (2000-17)	-0.8*
* The APC/AAPC is significantly different from zero (p<.05).

Preliminary Cancer Incidence Rates and Trends: Preliminary Estimates for 2017 Predicted Trends from Early Data Adjusted for Case Undercounts, SEER 18 Registries

Preliminary 5-year Average Annual Percent Change (AAPC) EstimatesBased on Joinpoint Analyses 2000-2017

February 2019 SEER Submission, SEER 18 Registries

Preliminary 5-year AAPC EstimatesMale, All Races

Preliminary 5-year AAPC EstimatesFemale, All Races

Preliminary 5-year AAPC EstimatesMale, White

Preliminary 5-year AAPC EstimatesFemale, White

Preliminary 5-year AAPC EstimatesMale, Black

Preliminary 5-year AAPC EstimatesFemale, Black

5-year Delay-Adjusted Ratesa